Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March–April 2020Expedited Published on 2020-08-012022-10-31 Journal: Emerging Infectious Diseases [Category] COVID-19, MERS, SARS, [키워드] California cardiovascular disease conditions coronavirus disease coronavirus diseases COVID-19 COVID-19 patients death rate hospital Hospitalization Hospitalized hospitalized COVID-19 patient ICU intensive care Limited median Mortality outcome outcomes Patient patients patients hospitalized Pneumonia pulmonary disease Region reported respiratory diseases San Francisco Bay SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 the United State United States USA viruses Volume with COVID-19 zoonoses [DOI] 10.3201/eid2608.201776 PMC 바로가기 [Article Type] Expedited
SARS-CoV-2 seroprevalence among parturient women in PhiladelphiaReports Published on 2020-07-292022-10-28 Journal: Science Immunology [Category] COVID-19, Fulltext, SARS, [키워드] affected Clinical practice Community COVID-19 donors IgG IgM individual Limited nasopharyngeal over parturient Philadelphia polymerase chain populations positive Pregnancy pregnant women Receptor binding domain SARS-CoV-2 SARS-CoV-2 seroprevalence SARS-CoV-2 spike SARS-CoV-2-specific antibodies serological evidence serological test Serological testing seropositive Surveillance women [DOI] 10.1126/sciimmunol.abd5709 PMC 바로가기 [Article Type] Reports
SARS‐CoV‐2 infection associated acute kidney injury in patients with pre‐existing chronic renal disease: A report of two casesOriginal Research Published on 2020-07-282022-10-30 Journal: Immunity, Inflammation and Disease [Category] COVID-19, MERS, SARS, [키워드] 2019 novel coronavirus Acute kidney injury acute respiratory syndrome aggravate Atypical change China Chronic kidney disease chronic renal disease Clinical characteristics Computed tomography consolidation coronavirus coronavirus disease coronavirus nucleic acid COVID‐19 COVID‐19 patient COVID‐19 criteria described diagnosed discharge driving dry cough female Fever impairment Infection information Intervention Kidney disease Limited lobe male MONITOR outbreak outcome patchy Patient patients Pneumonia positive Prognosis prognosis of patient public health renal renal function restored SARS‐CoV‐2 infection SARS‐CoV‐2 Shortness of breath Support symptomatic Thorax throat swab Treatment Wuhan [DOI] 10.1002/iid3.333 PMC 바로가기 [Article Type] Original Research
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for AnticoagulationReview Published on 2020-07-172022-10-31 Journal: Clinical and applied thrombosis/hemostasis : offic [Category] COVID-19, MERS, SARS, [키워드] Adapted addition Anticoagulant anticoagulation bleeding event can be used caused characterized coagulation parameter Coagulopathy complex COVID-19 cytokine d -dimer death decrease dosage dose effective Effects exaggerated inflammatory response Factor hematology IMPROVE incidence increase in Limited LMWH lung failure manifestation Microvascular thrombosis new coronavirus SARS-CoV-2 Novel coronavirus infection outcome parameter Patient patients patients with COVID-19 prognostic proportion rationale reduction in reported risk Sepsis severe COVID-19 manifestations severe COVID-19 patients shown Society Standard dose syndrome thrombosis [DOI] 10.1177/1076029620938149 PMC 바로가기 [Article Type] Review
Mutational Frequencies of SARS-CoV-2 Genome during the Beginning Months of the Outbreak in USAArticle Published on 2020-07-132022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] accumulate accumulated accumulated mutations America Analysis analyzed bioinformatics changes in circulating conserved COVID-19 determine functions Genetic variation Genome Helicase help Limited majority Month Mutation nsp10 NSP11 Nsp7 ORF3a ORF6 ORF7b ORF8 pandemic potential therapeutic target Protein Proteins provide RdRP Receptor binding domain Region Replication reported RNA virus SARS-CoV-2 SARS-CoV-2 genome SARS-CoV2 spike Spread submitted USA viral gene viral genome Viral protein virus propagation WHO [DOI] 10.3390/pathogens9070565 PMC 바로가기 [Article Type] Article
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2Review Published on 2020-07-082022-10-31 Journal: Future Medicinal Chemistry [Category] COVID-19, SARS, [키워드] anti-SARS-CoV-2 antiviral drug Chloroquine clinical trials clinically COVID-19 drug drug design drugs effective global pandemic Host Limited MPro organization potential therapeutic target promoted RdRP Remdesivir reported repositioning antiviral drugs Research SARS-CoV-2 specific antiviral drugs Spread Structure target protein target proteins therapeutic drug [DOI] 10.4155/fmc-2020-0158 PMC 바로가기 [Article Type] Review
General Model for COVID-19 Spreading With Consideration of Intercity Migration, Insufficient Testing, and Active Intervention: Modeling Study of Pandemic Progression in Japan and the United StatesOriginal Paper Published on 2020-07-032022-10-31 Journal: JMIR Public Health and Surveillance [Category] COVID-19, [키워드] China confirmed case confirmed cases coronavirus disease country COVID-19 COVID-19 infection develop drastic effect of intervention effective Effectiveness elevated expected generate hygiene implementation individual infected cases infected individual Insufficient Intervention Japan Limited Model modeling number of infected objective pandemic pandemic spreading parameter performed predict prediction profile progression raising reduced Region reported Result SEICR model social distancing Spread spread of COVID-19 spreading Stepping Testing the United State The United States Travel Wuhan, China [DOI] 10.2196/18880 PMC 바로가기 [Article Type] Original Paper
Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and reviewReview article Published on 2020-07-012022-10-05 Journal: Clinical biochemistry [Category] SARS, 바이오마커, [키워드] abnormality Analysis Biomarker Biomarkers calculate cardiac troponin changes in children children with COVID-19 CK-MB clinical chemistry Course COVID-19 COVID-19 case Creatine kinase-MB CRP decrease disease disease severity elevated eligible estimate highlight Hospitalized hospitalized patient Inflammation Injury Laboratory laboratory abnormality laboratory-confirmed lactate dehydrogenase LDH leukocyte Limited marker Meta-analysis Mild MONITOR parameter PCT pediatric Pediatric case pediatrics performed physician PPE Prevalence procalcitonin Protein question reliability reported SARS-CoV-2 Severe case severe coronavirus disease severe COVID-19 severe disease utility [DOI] 10.1016/j.clinbiochem.2020.05.012 [Article Type] Review article
Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource SettingsOriginal Research Published on 2020-07-012022-10-31 Journal: Global Heart [Category] COVID-19, [키워드] approach asymptomatic phase cardiovascular cardiovascular disease cardiovascular system Chagas disease clinical guideline Community Confirmed Consensus coronary syndrome coronavirus coronavirus disease COVID-19 COVID-19 illness COVID-19 patients CVD diabetes disease facilitate healthcare Healthcare professional heart failure hypertension individual interact International Limited Low income countries low resource settings management manifestation middle income countries myocardial injury National novel coronavirus disease outcome pandemic Patient patients with COVID-19 potential mechanism prognostic recommendation recommendations regions required Research resource respiratory SARS-CoV-2 setting severe COVID-19 susceptible Suspected Transmission transmitted [DOI] 10.5334/gh.823 PMC 바로가기 [Article Type] Original Research
Corticosteroid administration for viral pneumonia: COVID-19 and beyondNarrative Review Published on 2020-06-272022-11-01 Journal: Clinical microbiology and infection : the official [Category] COVID-19, [키워드] acute respiratory distress acute respiratory syndrome administration Anti-inflammatory effects clinical symptom clinician Cochrane Library content coronavirus disease Corticosteroid corticosteroid therapy corticosteroid treatment COVID-19 criteria Critical disease dose Effect Effectiveness evaluate the effect Evidence Factor Fatality rate improvement increased mortality individual Inflammatory response Influenza Limited lymphopenia manuscript MERS MERS-CoV Middle East Mortality Nosocomial infection objective observational studies observational study Oxygenation pandemic Patient people with COVID-19 potential mechanism Randomized controlled trial receive reduce reported SARS SARS Coronavirus SARS-CoV SARS-CoV-2 searched severe COVID-19 severe disease severe viral pneumonia severity significantly higher Source Symptom syndrome therapy Viral pneumonia virus clearance Web of Science were used [DOI] 10.1016/j.cmi.2020.06.020 PMC 바로가기 [Article Type] Narrative Review